IVX vs MSB

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IVX

INVION FPO [IVX]

38LOW

MSB

MESOBLAST FPO [MSB]

38LOW

Score Breakdown

IVX MSB
Technical
54
55
Catalyst
53
54
Sentiment
50
50
Fundamental
17
66
Momentum
44
67
Risk Gate
45
40

Key Metrics

IVX Metric MSB
$7.4MMarket Cap$2.7B
78KAvg Volume (20d)4.4M
N/AShort Interest+8.3%
$0.20052-Week High$3.310
$0.07552-Week Low$1.515
+0.0%Daily Change+6.3%
$0.076Entry Price$2.190
-111.5%ROE-18.2%
N/AProfit Margin-144.3%

Active Signals

IVX Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.2 quarters)
●Pre-revenue with limited cash
●Piotroski F-Score weak (2/9, low-confidence approx)

MSB Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare IVX and MSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IVX Full Analysis → MSB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).